Targeting unexplored G protein-coupled receptors (GPCRs) in the brain with novel small-molecule and neuropeptide mimetics for the treatment of rare and neglected Central Nervous System (CNS) diseases.



 Developing novel small molecule and peptide drugs for bone and brain diseases.